Biodegradable polymeric microcapsules for sustained release of riboflavin. 2016

A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt; Solid dosage forms Department, EIPICO, Egypt.

In the current study, a series of polylactic acid and polylactic-co-glycolic acid were prepared in an easy, simple, safe and economically feasible way with yield% greater than 90%. Studying the effect of a catalyst on polymerization process was performed. Riboflavin (RF) was chosen as a model drug and microencapsulated in different (drug: polymer) ratios to modify its performance via o/w emulsion solvent evaporation technique and characterized in terms of the morphology and entrapment efficiency (E.E.) and evaluated via in vitro RF release studies. It has been found that, the release rate consists a burst release at the first 12h, followed by a gradual release over 3days. The cumulative riboflavin release from these microcapsules formulations at the end of 3days was 70% and 80% for PDLA and PDLAGA respectively. The kinetics of release profiles were zero order. The highest (E.E.) of RF obtained among all formulations was 85%.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011091 Polyesters Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. Polyester
D011100 Polyglycolic Acid A biocompatible polymer used as a surgical suture material. Polyglycolide,Biofix,Dexon (Polyester),Dexon-S,Dexon S,DexonS
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D000077182 Polylactic Acid-Polyglycolic Acid Copolymer A co-polymer that consists of varying ratios of polylactic acid and polyglycolic acid. It is used as a matrix for drug delivery and for BONE REGENERATION. PLGA Acid,LactoSorb,PL-PG Copolymer,PLG Polymer,PLGA Compound,Poly (D,L-lactic-co-glycolic Acid),Poly (Lactic-co-glycolic Acid) -,Poly(D,L-lactide-co-glycolide),Poly(DL-lactide-co-glycolic Acid),Poly(Glycolide-co-lactide),Poly(L-lactide)-co-glycolide,Poly(Lactic-co-glycolic Acid),Poly-L-lactic-polyglycolic Acid,Polylactic-co-glycolic Acid Copolymer,RG 502,Acid, PLGA,Acids, PLGA,Copolymer, PL-PG,Copolymer, Polylactic-co-glycolic Acid,Copolymers, PL-PG,Copolymers, Polylactic-co-glycolic Acid,PL PG Copolymer,PL-PG Copolymers,PLG Polymers,PLGA Acids,PLGA Compounds,Poly L lactic polyglycolic Acid,Poly-L-lactic-polyglycolic Acids,Polylactic Acid Polyglycolic Acid Copolymer,Polylactic co glycolic Acid Copolymer,Polylactic-co-glycolic Acid Copolymers,Polymer, PLG,Polymers, PLG
D012256 Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as FLAVIN MONONUCLEOTIDE and FLAVIN-ADENINE DINUCLEOTIDE. Vitamin B 2,Vitamin G,Vitamin B2

Related Publications

A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
August 2017, Small (Weinheim an der Bergstrasse, Germany),
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
December 2011, AAPS PharmSciTech,
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
January 1997, Journal of microencapsulation,
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
July 1997, Current eye research,
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
December 2002, Farmaco (Societa chimica italiana : 1989),
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
February 2021, Polymers,
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
May 2006, Journal of controlled release : official journal of the Controlled Release Society,
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
January 1990, NIDA research monograph,
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
January 2001, Journal of microencapsulation,
A M Abd El-Hay, and A M Naser, and A Badawi, and M A Abd El-Ghaffar, and H Abd El-Wahab, and Doaa A Helal
March 2001, Yao xue xue bao = Acta pharmaceutica Sinica,
Copied contents to your clipboard!